Heartburn
Studies from R. Fass and Co-Researchers in the Area of Heartburn Published
Published in Biotech Week, April 11th, 2012
2012 APR 11 -- According to the authors of recent research from Deerfield, Illinois, "Many patients with gastroesophageal reflux disease (GERD) take a proton pump inhibitor (PPI) twice daily to control symptoms. Once-daily dexlansoprazole modified release (MR) has a dual-delayed release formulation, making it attractive for step-down management of patients whose symptoms are well controlled on twice-daily PPIs."
"We investigated whether step-down to once-daily dexlansoprazole controls heartburn in patients with GERD who were receiving twice-daily PPI therapy. Patients 18 years and older taking a twice-daily PPI for symptom control were enrolled (n = 178) in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
Source: Biotech Week (2012-04-11)
More Articles from Biotech Week
- Diabetes
iCo Therapeutics and JDRF team up to support iDEAL trial for diabetic macular edema - Breast Cancer
Xavier University of Louisiana Details Research in Breast Cancer - Pulmonary Embolism
XARELTO(R) rivaroxaban Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study - Clinical Trial Research
Writing the book of cancer knowledge - Diabetes
Vitamin D-fortified yogurt drink may lower risk of heart disease in type 2 diabetics - Platinum Compounds
Virginia Commonwealth University Details Research in Platinum Compounds - More from this issue of Biotech Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
